Read articles from North America

October 14, 2026 by brusselsmorning.com

A nicotine “market freeze” would lock Europe into today’s options instead of allowing better, lower-risk products to emerge. Innovation should not be given a free pass, but it should be assessed through evidence, standards and real-world impact rather than blocked in advance. Freezing the market could leave cigarettes protected while future smoke-free alternatives are kept out. Europe needs regulation that can manage risk without closing the door on progress.

October 14, 2026 by brusselsmorning.com

A nicotine “market freeze” would lock Europe into today’s options instead of allowing better, lower-risk products to emerge. Innovation should not be given a free pass, but it should be assessed through evidence, standards and real-world impact rather than blocked in advance. Freezing the market could leave cigarettes protected while future smoke-free alternatives are kept out. Europe needs regulation that can manage risk without closing the door on progress.

October 14, 2026 by clearingtheair.eu

Anti-nicotine campaigns rarely present themselves as propaganda; they present themselves as protection. That is why scrutiny matters. Funding networks, advocacy strategies and institutional alliances can shape which evidence is amplified, which voices are excluded and how safer nicotine products are framed to the public. A serious public health debate should be able to follow the influence behind the message, especially when the result may be fewer options for adults trying to leave cigarettes behind.

October 14, 2026 by substack.com

Tobacco harm reduction does not require nicotine to be innocent. It requires honesty about where the greatest harm comes from. Nicotine can cause dependence and should not be promoted casually, but cigarettes are deadly because they burn tobacco and expose users to toxic smoke. The case for safer nicotine products rests on reducing that exposure — not on pretending nicotine has no risks.

October 13, 2026 by daily-pouch.com

Nicotine entering wellness culture creates a communication challenge public health cannot ignore. A product may be smoke-free and far less harmful than cigarettes, but that does not make nicotine a lifestyle supplement or a harmless productivity tool. The clearest message is also the most nuanced: non-combustible nicotine can matter for smokers moving away from combustion, while non-users should not be encouraged to start. Risk communication needs to hold both truths at once.

October 13, 2026 by weareinnovation.global

Banning products before they even exist is not precaution; it is policy closing its eyes to innovation. Eight EU capitals pushing restrictions on future nicotine products risk freezing the market around what already exists, including cigarettes. New products should face evidence, standards and scrutiny, not pre-emptive exclusion based on category fear. A smarter European approach would regulate risk as it emerges, while keeping the door open to technologies that could help move smokers further away from combustion.

October 12, 2026 by washingtonexaminer.com

The FDA review backlog is not just an administrative problem; it shapes the market smokers actually face. Legal smoke-free products wait in uncertainty, while illicit and unapproved products move faster than the system designed to regulate them. That imbalance leaves adult smokers with fewer accountable options and gives the black market more space to grow. Product review should be rigorous, but it also has to be timely enough to support harm reduction in the real world.

October 09, 2026 by regulatorwatch.com

A reset of the FDA’s PMTA process is overdue if regulation is meant to guide the market rather than paralyse it. The current pathway has left many smoke-free products trapped in uncertainty while cigarettes remain legally available and illicit alternatives gain space. A better system should be rigorous, transparent and fast enough to distinguish responsible products from those that do not meet standards. Harm reduction depends on regulation that can make timely decisions, not one that delays safer options out of reach.

October 09, 2026 by pearlsandirritations.com

Australia’s nicotine policy is drifting further from the reality consumers are living in. Cigarettes remain legal, illicit tobacco is expanding, and many vapers are navigating workarounds, informal supply or rules that do not match how people actually quit smoking. That gap matters because policy cannot reduce harm effectively while pretending demand has disappeared or that restriction equals control. A better approach would start from real behaviour: keep people inside legal channels, make safer alternatives accessible, and measure success by fewer people smoking.

October 09, 2026 by clearingtheair.eu

Europe’s nicotine debate is becoming a house divided. Some countries are moving towards risk-proportionate regulation, while others are pushing bans, higher taxes and restrictions that may leave cigarettes in a stronger position. That split matters because smokers across Europe are not facing the same chances to move away from combustion. A coherent EU strategy should protect young people, recognise product differences and make the lower-risk route easier to take than the deadly one.